{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T13:07:40Z","timestamp":1758200860317,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l'Education Nationale, de l'Enseignement Superieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.atherosclerosis.2008.05.045","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T04:16:24Z","timestamp":1212552984000},"page":"119-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alterations in the transfer of phospholipids from very-low density lipoproteins to activated platelets in type 2 diabetes"],"prefix":"10.1016","volume":"203","author":[{"given":"Salam","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Pruneta-Deloche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybil","family":"Charri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Calzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Guichardant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Lagarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Ponsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.ATV.12.6.647","article-title":"George Lyman Duff Memorial Lecture Atherogenesis in diabetes","volume":"12","author":"Bierman","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","article-title":"Lipids and lipoproteins in patients with type 2 diabetes","volume":"27","author":"Krauss","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1538-7836.2003.00072.x","article-title":"Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus","volume":"1","author":"De Cristofaro","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diabetes.53.4.1046","article-title":"Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status","volume":"53","author":"V\u00e9ricel","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0165-6147(93)90028-I","article-title":"Modulation of platelet function by free radicals and free-radical scavengers","volume":"14","author":"Salvemini","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib6","first-page":"42","article-title":"Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications","volume":"12","author":"Ceriello","year":"1999","journal-title":"Diabetes Nutr Metab"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1368-5031.2006.00825.x","article-title":"Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia","volume":"60","author":"Wright","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib8","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1074\/jbc.272.21.13597","article-title":"Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte\/endothelial interactions and evidence for their presence in vivo","volume":"272","author":"Watson","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/dmrr.491","article-title":"Lipoproteins, glycoxidation and diabetic angiopathy","volume":"20","author":"Jenkins","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1388-1981(99)00181-X","article-title":"High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences","volume":"1483","author":"Francis","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s001250051333","article-title":"Very low density lipoprotein subfractions in type II diabetes mellitus: alterations in composition and susceptibility to oxidation","volume":"43","author":"McEneny","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1042\/bst0311062","article-title":"Oxidative modification of triacylglycerol-rich lipoproteins","volume":"31","author":"Young","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1055\/s-0037-1614909","article-title":"Early platelet activation by low density lipoprotein via p38MAP kinase","volume":"82","author":"Hackeng","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00018-003-2249-y","article-title":"Low-density lipoprotein and its effect on human blood platelets","volume":"60","author":"Relou","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/diabetes.52.5.1248","article-title":"A novel role for CD36 in VLDL-enhanced platelet activation","volume":"52","author":"Englyst","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0163-7827(88)90008-2","article-title":"Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function","volume":"27","author":"Lagarde","year":"1988","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib17","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(00)02175-9","article-title":"Platelets","volume":"355","author":"George","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib18","doi-asserted-by":"crossref","first-page":"10534","DOI":"10.1016\/S0021-9258(18)82231-1","article-title":"Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor A possible function for phosphatidylcholine-derived diacylglycerol","volume":"268","author":"Ha","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/bj2910329","article-title":"Protein kinase C isoenzymes: divergence in signal transduction","volume":"291","author":"Hug","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0929-7855(95)00012-F","article-title":"Cytosolic phospholipase A2","volume":"12","author":"Clark","year":"1995","journal-title":"J Lipid Mediat Cell Signal"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1146\/annurev.bi.47.070178.005025","article-title":"Prostaglandins and thromboxanes","volume":"47","author":"Samuelsson","year":"1978","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/bj3150781","article-title":"Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets","volume":"315","author":"Engelmann","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0014-5793(98)01687-1","article-title":"Platelet high affinity low density lipoprotein binding and import of lipoprotein derived phospholipids","volume":"444","author":"Dobner","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib24","doi-asserted-by":"crossref","first-page":"27800","DOI":"10.1074\/jbc.273.43.27800","article-title":"Platelet agonists enhance the import of phosphatidylethanolamine into human platelets","volume":"273","author":"Engelmann","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1194\/jlr.M500209-JLR200","article-title":"Transfer of very low density lipoprotein-associated phospholipids to activated human platelets","volume":"47","author":"Ibrahim","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1194\/jlr.M600480-JLR200","article-title":"The transfer of VLDL-associated phospholipids to activated platelets depends upon cytosolic phospholipase A2 activity","volume":"48","author":"Ibrahim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0076-6879(94)33023-9","article-title":"Enzymatic and immunological measurements of soluble and membrane-bound phospholipid\u2013hydroperoxide glutathione peroxidase","volume":"233","author":"Roveri","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1365-2362.1996.125258.x","article-title":"Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes","volume":"26","author":"Elchebly","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0049-3848(80)90098-5","article-title":"A simple and efficient method for platelet isolation from their plasma","volume":"17","author":"Lagarde","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00041433-199306000-00003","article-title":"Lipoprotein lipase and hepatic lipase","volume":"4","author":"Olivecrona","year":"1993","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1194\/jlr.M300435-JLR200","article-title":"Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes","volume":"45","author":"Pruneta-Deloche","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidemia: from basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib35","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-2275(20)33868-2","article-title":"Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL","volume":"39","author":"Whitman","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib36","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.75.9.4519","article-title":"Formation of high density lipoprotein 2-like particles during lipolysis of very low density lipoproteins in vivo","volume":"75","author":"Patsch","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib37","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.febslet.2007.02.043","article-title":"CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis","volume":"581","author":"Thorne","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib38","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0891-5849(03)00386-1","article-title":"Activation of p38 mitogen-activated protein kinase\/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets","volume":"35","author":"Coulon","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.atherosclerosis.2008.05.045_bib39","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0022-2275(20)30280-7","article-title":"12(S)-Hydroperoxy-eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets","volume":"42","author":"Calzada","year":"2001","journal-title":"J Lipid Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008003778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008003778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:29:08Z","timestamp":1758155348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915008003778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0021915008003778"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.05.045","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in the transfer of phospholipids from very-low density lipoproteins to activated platelets in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}